- Home
- DAWN vs GDYN Comparison
DAWN vs GDYN Comparison
Compare DAWN & GDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | GDYN |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.8M | 727.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DAWN | GDYN |
|---|---|---|
| Price | $7.97 | $9.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $26.56 | $11.25 |
| AVG Volume (30 Days) | ★ 2.8M | 877.4K |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 457.52 |
| EPS | N/A | ★ 0.16 |
| Revenue | $133,672,000.00 | ★ $405,955,000.00 |
| Revenue This Year | $15.51 | $19.77 |
| Revenue Next Year | $49.99 | $10.24 |
| P/E Ratio | ★ N/A | $58.16 |
| Revenue Growth | ★ 31.11 | 23.63 |
| 52 Week Low | $5.64 | $7.37 |
| 52 Week High | $13.92 | $25.50 |
Technical Indicators
Market Signals| Indicator | DAWN | GDYN |
|---|---|---|
| Relative Strength Index (RSI) | 42.36 | 65.66 |
| Support Level | $8.16 | $8.57 |
| Resistance Level | $8.60 | $9.82 |
| Average True Range (ATR) | 0.54 | 0.37 |
| MACD | -0.17 | 0.12 |
| Stochastic Oscillator | 2.16 | 82.80 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.